Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy
Authors:
- Andrea FrustaciAFAndrea Frustaci
- Emanuela MorganteEMEmanuela Morgante
- Daniela AntuzziDADaniela Antuzzi
- Matteo Antonio RussoMRMatteo Antonio Russo
- Cristina ChimentiCCCristina Chimenti
- 1 May 2012
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 157 (1) , 117-119
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Statement on authorship and publishing ethics in the international journal of cardiologyInternational Journal of Cardiology, 2011
- Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome SurveyEuropean Journal of Clinical Investigation, 2004
- Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry DiseaseCirculation, 2003
- Chloroquine cardiotoxicityCardiovascular Pathology, 2002
- Cardiac toxicity secondary to long term treatment with chloroquineAnnals of the Rheumatic Diseases, 2001